Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ZimVie Inc. - Common Stock (NQ: ZIMV )

18.95 +0.27 (+1.45%)
Streaming Delayed Price Updated: 9:33 AM EDT, Jul 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ZimVie Inc. - Common Stock

< Previous 1 2 Next >
ZimVie to Participate in Upcoming Investor Conferences
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports First Quarter 2024 Financial Results
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report First Quarter Financial Results on May 8, 2024
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Closing of Sale of Spine Business
Completion of Sale to an Affiliate of H.I.G. Capital for $375 Million Establishes Pure-Play Dental Business 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
Newest implant innovation is designed for immediacy and peri-implant health 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma Navigation
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
New offerings expand ZimVie’s dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
New offering broadens ZimVie’s dental portfolio into the expanding growth factor biomaterials market 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces FDA Approval for New Mobi-C® Implant
Smaller height implants in all Mobi-C footprints to address patient anatomy 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Present at the Stifel 2023 Jaws & Paws Conference
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance
From ZimVie Inc.
Via GlobeNewswire
ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida
Modernized 11,000 sq. ft. facility equipped for hands-on dental education and training underscores company’s commitment to lead the industry in advancing professional development of dental... 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug
New offerings in ZimVie’s extensive portfolio of dental bone graft solutions enhance selection for customers and bolster cadence of recent product launches 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
Mobi-C obtains French government reimbursement and the highest quality rating from the British clinical data panel ODEP 
From ZimVie Inc.
Via GlobeNewswire
ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
Publication highlights Puros Cancellous Particulate Allograft’s collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to... 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering
The Tether™ device now deemed “medically necessary” for the treatment of pediatric scoliosis in additional patients covered by Highmark and BCBS North Dakota 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
From ZimVie Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.